Determination of azelnidipine in human plasma by liquid chromatography-electro spray ionization-mass spectrometry

被引:18
作者
Ding, Li
Li, Li
Ma, Pengcheng
机构
[1] China Pharmaceut Univ, Dept Pharmaceut Anal, Nanjing 210009, Peoples R China
[2] Chinese Acad Med Sci, Dermatol Hosp, Org State Drug Clin Trial, Nanjing, Peoples R China
关键词
azelnidipine; LC-ESI-MS; pharmacokinetics;
D O I
10.1016/j.jpba.2006.07.011
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) method for the determination of azelnidipine in human plasma was established. Nicardipine was used as the internal standard (IS). After adjustment to a basic pH with sodium hydroxide solution (0.1 M), plasma samples were extracted with cyclohexane-diethyl ether (1:1, v/v)and separated on a C-18 column with a mobile phase of 20 mM ammonium acetate solution-methanol-formic acid (25:75:0.5, v/v). The electrospray ionization was employed in a single quadrupole mass spectrometer for the determination. The method was linear over the concentration range of 0.05-40 ng/ml. The lower limit of quantification (LLOQ) was 0.05 ng/ml. The intra- and inter-run standard deviations were less than 9.5% and 11.0%, respectively. The method was successfully applied to study the pharmacokinetics of azelnidipine in healthy Chinese volunteers. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 5 条
[1]   Determination of glycyrrhetic acid in human plasma by LC-ESI-MS [J].
Ding, L ;
Huang, X ;
Yang, J ;
Bian, XJ ;
Zhang, ZX ;
Liu, GY .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (03) :758-762
[2]  
Koike H, 2002, ANN REP SANKYO RES L, V54, P1
[3]   Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure [J].
Kuramoto, K ;
Ichikawa, S ;
Hirai, A ;
Kanada, S ;
Nakachi, T ;
Ogihara, T .
HYPERTENSION RESEARCH, 2003, 26 (03) :201-208
[4]   Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells [J].
Ma, X ;
Kishida, S ;
Wang, GQ ;
Meguro, K ;
Imuta, H ;
Oonuma, H ;
Iida, H ;
Jo, T ;
Takano, H ;
Morita, T ;
Nagai, K ;
Nakajima, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 (02) :314-321
[5]  
*US DEP HHS CDER F, 2001, GUID IND BIOAN METH